José Antonio Allué

Author

José Antonio Allué

Skåne University Hospital ORCID

Also Known As

J.A. Allúe, Jose A. Allue, Jose A. Allué, José Antonio Allué

Publications

Citations

H-Index

Concepts

All Affiliations

Skåne University Hospital University College London Grifols (Spain)Lund University University of Gothenburg

About

José Antonio Allué is an author at Skåne University Hospital specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	213
2	Neuroscience	3	3	213
3	Neurology	2	2	201
4	Social Sciences	1	1	12
5	Pathology	1	1	12

José Antonio Allué

Publications

979

Citations

H-Index

Page 1

	Year	Citations
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease Shorena Janelidze, Charlotte E. Teunissen, Henrik Zetterberg, JAMA Neurology	2021	474
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau Shorena Janelidze, Sebastian Palmqvist, Antoine Leuzy, Alzheimer s & Dementia	2021	193
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations Nicholas Cullen, Antoine Leuzy, Sebastian Palmqvist, Nature Aging Alzheimer's DiseasePlasma Biomarker CombinationsMedicineDementiaVascular Cognitive Disorder	2020	189
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline María Pascual‐Lucas, José Antonio Allué, Leticia Sarasa, Alzheimer s Research & Therapy	2023	38
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort Hyemin Jang, Ji Sun Kim, Hye Joo Lee, Alzheimer s Research & Therapy	2021	33
Aβ1-17 is a Major Amyloid-β Fragment Isoform in Cerebrospinal Fluid and Blood with Possible Diagnostic Value in Alzheimer's Disease Virginia Pérez‐Grijalba, Pedro Pesini, José Antonio Allué, Journal of Alzheimer s Disease	2014	18
Identification of β-amyloid species in canine cerebrospinal fluid by mass spectrometry Leticia Sarasa, José Antonio Allué, Pedro Pesini, Neurobiology of Aging Neuroimaging BiomarkersNeurodegenerative Diseasesβ-Amyloid SpeciesCerebrospinal FluidCanine Cerebrospinal Fluid	2013	12
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease José Antonio Allué, Leticia Sarasa, María Izco, Journal of Alzheimer s Disease NeurogenomicsTransgenic Mouse ModelsBiological Mass SpectrometryNeurochemical BiomarkersAlzheimer ’	2016	12
Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study José Antonio Allué, María Pascual‐Lucas, Leticia Sarasa, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2023	10

Page 1